Supreme court sets aside Myriad gene patent ruling

by jeeg 26. March 2012 20:18
The Supreme Court set aside on Monday a ruling that Myriad Genetics Inc can patent two genes linked to breast and ovarian cancers, in a case closely watched by the biotechnology industry. The justices set aside a ruling by the U.S. Court of Appeals for the Federal Circuit that Myriad has the ... [More]

Myriad Cert Petition Now Fully Briefed; Supreme Court May Decide (to take up Gene Patent Case) by Feb. 20

by jeeg 13. February 2012 22:21
Petitioners challenging the patent eligibility of isolated DNA filed a reply brief Jan. 20, rejecting the respondent patent owner's call for the U.S. Supreme Court to deny review of the case for lack of standing (Association for Molecular Pathology v. Myriad Genetics Inc., U.S., No. 11-725, re... [More]

Gene Patents "Like Trying to Keep Water in a Sieve"

by jeeg 25. October 2011 01:27
Last week, the American Civil Liberties Union (ACLU) announced they will ask the Supreme Court to rule on the gene diagnostics company Myriad Genetics' patents on "isolated" BRCA-1 and BRCA-2 genes, two genes that can have mutations linked to breast and ovarian cancer, as well as prostate canc... [More]

New Issue of GeneWatch Magazine on the Global Human Rights Challenges of Forensic DNA

by jeeg 3. October 2011 20:39
DNA testing was initially introduced into the criminal justice system on a case by case basis as a method of developing supplemental evidence to be used in convicting those guilty of committing violent felonies.  Over just a short time, however, the balance between the legitimate needs of... [More]

Gene rights ban rejected

by jeeg 22. September 2011 19:57
A PROPOSED ban on the controversial patenting of human genetic material has lost the support of a Senate committee which threatens to renew the intense debate that has pitched patients and doctors against researchers and biotech companies. A narrow majority of the Senate Legal and Constitutio... [More]

NHS ignores gene patents, experts say

by jeeg 8. August 2011 23:49
Genetic testing laboratories in the National Health Service are deliberately ignoring most patents on DNA, experts told a meeting in London on Friday. “The view from the NHS is that, for diagnostics, gene patents are unacceptable, unenforceable and detrimental to the delivery of patient... [More]

Private companies own your DNA – again

by jeeg 1. August 2011 19:09
Many scientists cheered last year when a federal judge ruled that human genes couldn’t be patented. The case involved Myriad Genetics, which holds the patent rights on two genes, BRCA1 and BRCA2, that are associated with increased risks for breast and ovarian cancer. Thanks to these pate... [More]

New Issue of GeneWatch Magazine on Assisted Reproductive Technologies (ART)

by jeeg 21. July 2011 20:52
Your knowledge of in vitro fertilization and multiple embryo transfers might begin and end at the case of Nadya Suleman, aka "Octomom." Perhaps you first learned of commercial surrogacy through Baby Mama, the 2008 comedy starring Tina Fey and Amy Poehler.  Or maybe you have already commit... [More]

IP Rules for Synthetic Bio Generate More Questions Than Answers

by jeeg 13. May 2011 23:05
The biotechnology world was rocked a year ago this month, when J. Craig Venter, Ph.D., reported that he led a team of 17 researchers at his namesake institute in completing the second of three key steps toward creating a fully synthetic organism. The team created the largest man-made DNA struc... [More]

Gene patents and democracy

by jeeg 1. April 2011 21:22
On 4 April, the US Court of Appeals for the Federal Circuit in Washington, DC will review a case that calls into question patents on human genes. Much of the debate has focused on how the case might reshape the future of biotechnology research and genomic medicine. But what is at least as impo... [More]
Log in